Beverly A. Guadagnolo
Beverly Ashleigh Guadagnolo, M.D., M.P.H., is associate professor of radiation oncology and health services research at the University of Texas MD Anderson Cancer Center. She served as member of the U.S. Department of Health and Human Services advisory committee on minority health, and on the technical expert panel of the Agency for Health Care Research and Quality project on radiotherapy treatments for head and neck cancer. She received a B.A. in biology from the University of Texas at Austin, M.D. from Harvard Medical School, and M.P.H from the Harvard School of Public Health where she held a National Cancer Institute fellowship in cancer prevention.
Joseph Lipscomb, Ph.D., is Georgia Cancer Coalition Distinguished Cancer Scholar and professor of health policy and management at the Rollins School of Public Health at Emory University. Previously, he was associate director for population sciences at Emory’s Winship Cancer Institute and a clinical investigator at the Kaiser Permanente Center for Health Research. He was also on the faculty of Duke University and the University of North Carolina at Chapel Hill, chief of the Outcomes Research Branch at the National Cancer Institute, and a study director at the National Academies of Sciences, Engineering, and Medicine. He has twice received the National Institutes of Health Award of Merit. He has served as a consultant in health economics, outcomes research, and program evaluation to American Cancer Society, SRA International, Amgen, Pfizer, Boehringer Ingelheim, Janssen, Dupont Merck, G.D. Searle, Society of Nuclear Medicine, Burroughs Wellcome, and PhRMA. He is chair of the Data and Evaluation Committee for the Georgia Cancer Control Consortium and is a member of the American College of Surgeons Commission on Cancer’s Quality Integration Committee, and was chair of American Cancer Society Health Services Research Advisory Committee. He received his B.A. from Vanderbilt University and Ph.D. from the University of North Carolina at Chapel Hill.
Maria E. Martinez
María Elena Martínez, Ph.D., M.P.H., is Sam M. Walton Endowed Chair for Cancer Research and professor of family and preventive medicine at the University of California, San Diego. She also serves as associate director of population sciences, disparities and community engagement at the Moores Cancer Center. Previously, she was professor of epidemiology in the Mel and Enid Zuckerman College of Public Health and was the Richard H. Hollen Professor of Cancer Prevention at the University of Arizona Cancer Center. She received a B.S. in nutrition from the University of Illinois, M.P.H. and a Ph.D. in epidemiology from the University of Texas School of Public Health. She completed a postdoctoral fellowship at the Harvard School of Public health. She is senior editor of the cancer disparities section for Cancer Epidemiology, Biomarkers & Prevention, and associated editor of the Journal of the National Cancer Institute. She has served as chair of the American Association for Cancer Research’s Minorities in Cancer Research Council, and was a member of the Cancer Moonshot Blue Ribbon Panel. She is a member of board of scientific advisors of the National Cancer Institute.
Mary S. McCabe
Mary McCabe, R.N., M.A., is former director of the Cancer Survivorship Program at Memorial Sloan-Kettering Cancer Center. She is a lecturer at Cornell Weill Medical College and Columbia University School of Nursing. She was chair of the Memorial Sloan-Kettering Cancer Center Ethics Committee and former director of nursing services at the Lombardi Cancer Center. She has been a director of the offices of clinical research promotion and of education and special initiatives at the National Cancer Institute, where she was also assistant director of the division of cancer treatment and diagnosis. She received her B.A. from Trinity College, B.S.N from Emory University, and M.A. from Catholic University. Her honors include the American Cancer Society Merit Award, Oncology Nursing Society Leadership Award, NIH Outstanding Performance Award, NIH Director’s Award, and Emory University’s Outstanding Alumnae Award. She is member of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine.
Leah Merchant, B.A., serves as section supervisor for the Montana Cancer Control Programs in the Montana Department of Public Health and Human Services. Her responsibilities include managing regional contracts with local public health departments across Montana to implement cancer education outreach and direct screening services, and leading statewide implementations efforts to address cancer policy issues affecting diverse populations. She is past chair of the cancer council of the National Association of Chronic Disease Directors. She received her B.A. degree from Smith College.
Jewel Mullen, M.D., M.P.H., M.P.A., is the former principal deputy assistant secretary for health at the U.S. Department of Health and Human Services. Previously, she served as commissioner of the Connecticut Department of Public Health. Earlier, she was director of the Bureau of Community Health and Prevention at the Massachusetts Department of Public Health, and former medical director of Baystate Mason Square Neighborhood Health Center. She began her clinical career as a member of the National Health Service Corps at Bellevue Hospital, New York, after which she joined the medical faculty of the University of Virginia. She has been a member of the medical staff at the Hospital of St. Raphael, the Yale University Health Services, and Yale New Haven Hospital. She received her B.S. and M.P.H. degrees from Yale University. She received her M.D. from the Mount Sinai School of Medicine and completed her internal medicine residency at University of Pennsylvania. She also received a M.P.A. from Harvard’s John F. Kennedy School of Government. She is former president of the Association of State and Territorial Health Officials.
Electra Paskett, Ph.D., is the Marion N. Rowley Professor of Cancer Research at the Ohio State University. She is also director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology, associate director for Population Sciences at the Comprehensive Cancer Center, and director of the Center for Cancer Health Equity at the Ohio State University. Previously, she was on the faculty of Wake Forest University School of Medicine and University of Missouri. She is past president of the American Society of Preventive Oncology and was chair of the American Public Health Association Cancer Forum. She is deputy editor of Cancer, Epidemiology, Biomarkers and Prevention and has served on the editorial boards of Cancer Prevention Research and Cancer. She received her B.S. from the University of Utah and Ph.D. from the University of Washington. She is recipient of the American Association for Cancer Research Dedication and Outstanding Achievement Award and the American Society of Preventive Oncology Distinguished Achievement Award. She is a fellow of the American Association for the Advancement of Science. She is a member of the National Cancer Advisory Board and has served as president of the American Society of Preventive Oncology.
George Poste, Ph.D., D.V.M., is Regent’s Professor and Del E. Webb Chair of Health Innovation, and director and chief scientist of the Complex Adaptive Systems at Arizona State University, where he was also the founding director of the Biodesign Institute. Previously, he was chief science and technology officer and president of R&D among other leadership positions at SmithKline Beecham (now GlaxoSmithKline). Earlier, he was a principal cancer research scientist at Roswell Park Memorial Institute (now Roswell Park Comprehensive Cancer Center). He has served on the Defense Science Board and on boards of numerous companies including Health Longevity, Inc., Haplogen GmbH, Synthetic Genomics, Caris Life Sciences (as vice-chair), Exelexis, Illumina, Maxygen, diaDexus (as chair; acquired by VaxGen), Structural Genomix (as chair; acquired by Eli Lilly), and AdvancePCS (acquired by CVS), Burrill and Company, and Monsanto. He has been a trustee of the Gordon Research Conferences, Royal Society of Medicine Foundation, Institute for Scientific Information, and BP Technology Advisory Council. He has served as a distinguished fellow at the Hoover Institution of Stanford University and on the board of medical governors of the World Economic Forum. He has received honorary doctorates from the University of Bristol (where he received his D.V.M. and Ph.D.) and the University of Dundee. His awards include the Global Business Leadership Forum’s Einstein Award and the Pharmaceutical Industry Leadership Forum’s Scrip Lifetime Achievement Award. He is a member of the Council on Foreign Relations, and a fellow of the U.K. Royal College of Pathologists, the Royal College of Physicians, the Royal Society of Arts, the Academy of Medical Sciences, and the Royal Society. He is a Commander of the British Empire.
William B. Rouse
William Rouse, Ph.D., is the Alexander Crombie Humphreys Chair and director of the Center for Complex Systems and Enterprises at Stevens Institute of Technology. Previously, he was a professor in the School of Industrial and Systems Engineering at the Georgia Institute of Technology. He was chief executive officer of two software companies—Enterprise Support Systems and Search Technology. He has held faculty positions at University of Illinois, Delft University of Technology, and Tufts University. Among many advisory roles, he has served as a member of the U.S. Air Force Scientific Advisory Board, and a member of the Department of Defense Senior Advisory Group on Modeling and Simulation. He has received the Joseph Wohl Outstanding Career Award and the Norbert Wiener Award from the IEEE Systems, Man, and Cybernetics Society; a Centennial Medal and a Third Millennium Medal from IEEE; and the O. Hugo Schuck Award from the American Automation Control Council. He is a fellow of IEEE, International Council on Systems Engineering, Institute for Operations Research and Management Science, and the Human Factors and Ergonomics Society. He is a member of the National Academy of Engineering.
William W. Stead
William Stead, M.D., is chief strategy officer for Vanderbilt University Medical Center, where he also holds appointments as the McKesson Foundation Professor of Biomedical Informatics and Professor of Medicine. He has served as president of the American College of Medical Informatics and chair of the board of regents of the National Library of Medicine. He is a founding fellow of the American College of Medical Informatics and the American Institute for Medical and Biological Engineering, and served as founding editor-in-chief of the Journal of the American Medical Informatics Association. He received his B.A., M.D., and residency training in internal medicine and nephrology from Duke University. His awards include the Collen Award for Excellence in Medical Informatics and the Lindberg Award for Innovation in Informatics. He is chair of the National Committee for Vital and Health Statistics of the U.S. Department of Health and Human Services. He is a member and former councilor of the National Academy of Medicine.
Cornelia Ulrich, Ph.D., is a Jon and Karen Huntsman Presidential Professor in Cancer Research at the University of Utah, where she is also senior director of population sciences at Huntsman Cancer Institute as well as professor and division chief of cancer population sciences in the Department of Population Health Sciences. She was on the faculty of University of Washington and was head of the Department of Preventive Oncology at the German Cancer Research Center and Director of the National Center for Tumor Diseases in Heidelberg, Germany. She was co-chair of the German Society of Epidemiology cancer group and a guest member of the committee for the implementation of the German Cancer Plan. She is senior editor for Cancer Epidemiology, Biomarkers & Prevention. She received her M.Sc. from Oregon State University and Ph.D. from University of Washington. She is a recipient of the American Association of Cancer Research Bristol-Myers Squibb Young Investigator Award, and is a fellow of the European Academy of Cancer Sciences.